Gaucher or pseudo-Gaucher? The challenge of several diseases colliding in a pediatric patient

Human Pathology

Volumn 40, Issue 4, 2009, Pages 594-598

  Cajaiba, Mariana M ^a   Reyes Múgica, Miguel ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gaucher disease; Lymphoma; Neurofibromatosis

Indexed keywords

GENOMIC DNA; GLUCOSYLCERAMIDASE;

ARTICLE; BONE MARROW; BONE MARROW BIOPSY; CANCER STAGING; CASE REPORT; CELL ASSAY; CELL INFILTRATION; CELL STRUCTURE; CELL ULTRASTRUCTURE; CHILD; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; GAUCHER DISEASE; GENE SEQUENCE; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; INCIDENTAL FINDING; MISSENSE MUTATION; NEUROFIBROMATOSIS; PATHOGENESIS; PRESCHOOL CHILD; T CELL LYMPHOMA;

CHILD; FEMALE; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HUMANS; NEUROFIBROMATOSIS 1; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 62049085567     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.09.003     Document Type: Article

References (30)

1. Beutler E. Gaucher disease as a paradigm of current issues regarding single gene mutations of humans. Proc Natl Acad Sci 90 (1993) 5384-5390
2. Zhao H., and Grabowski G.A. Gaucher disease: perspectives on a prototype lysosomal disease. Cell Mol Life Sci 59 (2002) 694-707
3. Kaplan P., Andersson H.C., Kacena K.A., and Yee J.D. The clinical and demographic characteristics of nonneuropathic Gaucher disease in 887 children at diagnosis. Arch Pediatr Adolesc Med 160 (2006) 603-608
4. Shiran A., Brenner B., Laor A., and Tatarsky I. Increased risk of cancer in patients with Gaucher disease. Cancer 72 (1993) 219-224
5. Zimran A., Liphshitz I., Barchana M., Abrahamov A., and Elstein D. Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic. Blood Cells Mol Dis 34 (2005) 197-200
6. Rosembloom B.E., Weinreb N.J., Zimran A., Kacena K.A., Charrow J., and Ward E. Gaucher disease and cancer incidence: a study from the Gaucher Registry. Blood 105 (2005) 4569-4572
7. Fost M., Dahl S., Weverling G.J., et al. Increased incidence of cancer in adult Gaucher disease in Western Europe. Blood Cells Mol Dis 36 (2006) 53-58
8. Lee R.E., and Ellis L.D. The storage cells of chronic myelogenous leukemia. Lab Invest 24 (1971) 261-264
9. Zidar B.L., Hartsock R.J., Lee R.E., et al. Pseudo-Gaucher cells in the bone marrow of a patient with Hodgkin's disease. Am J Clin Pathol 87 (1987) 533-536
10. Robak T., Urbanska-Rys H., Jerzmanowski P., Bartkowiak J., Liberski P., and Kordek R. Lymphoplasmacytic lymphoma with monoclonal gammopathy-related pseudo-Gaucher cell infiltration in bone marrow and spleen-diagnostic and therapeutic dilemmas. Leuk Lymphoma 43 (2002) 2343-2350
11. Fox H., McCarthy P., Andre-Schwartz J., Shoenfeld Y., and Miller K.B. Gaucher's disease and chronic lymphocytic leukemia. Cancer 54 (1984) 312-314
12. Costello R., O'Callaghan T., and Sebahoun G. Gaucher disease and multiple myeloma. Leuk Lymphoma 47 (2006) 1365-1368
13. Brody J.D., Advani R., Shin L.K., Bingham D.B., and Rosenberg S.A. Splenic diffuse large B-cell lymphoma in a patient with type 1 Gaucher disease: diagnostic and therapeutic challenges. Ann Hematol 85 (2006) 817-820
14. Burstein Y., Rechavi G., Rausen A.R., Frisch B., and Spirer Z. Association of Gaucher's disease and lymphoid malignancy in 2 children. Scand J Haematol 35 (1985) 445-447
15. Sanchez R., Etzell J., Kim G., Packman S., Fairley C., and Goldsby R. Peripheral T-cell lymphoma in an adolescent with unsuspected Gaucher disease. J Clin Oncol 23 (2005) 4792-4793
16. Pratt P.W., Estren S., and Kochwa S. Immunoglobulin abnormalities in Gaucher's disease. Blood 31 (1968) 633-639
17. Shoenfeld Y., Gallant L.A., Shaklai M., Livni E., Djaldetti M., and Pinkhas J. Gaucher's disease: a disease with chronic stimulation of the immune system. Arch Pathol Lab Med 106 (1982) 388-391
18. Marti G.E., Ryan E.T., Papadopoulos N.M., et al. Polyclonal B-cell lymphocytosis and hypergammaglobulinemia in patients with Gaucher disease. Am J Hematol 29 (1988) 189-194
19. Allen M.J., Myer B.J., Khokher A.M., Rushton N., and Cox T.M. Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10. QJM 90 (1997) 19-25
20. Hollak C.E.M., Evers L., Aerts J.M.F.G., and van Oers M.H.J. Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease. Blood Cells Mol Dis 23 (1997) 201-212
21. Barak V., Acker M., Nisman B., et al. Cytokines in Gaucher's disease. Eur Cytokine Netw 10 (1999) 205-210
22. Boot R.G., Verhoek M., Fost M., et al. Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention. Blood 102 (2004) 33-39
23. Boot R.G., Verhoek M., Langeveld M., et al. CCL18: a urinary marker of Gaucher cell burden in Gaucher patients. J Inherit Metab Dis 29 (2006) 564-571
24. Schutyser E., Richmond A., and Van Damme J. Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes. J Leukoc Biol 78 (2005) 14-26
25. Wimmer A. CCL18/PARC stimulates hematopoiesis in long-term bone marrow cultures indirectly through its effects on monocytes. Blood 108 (2006) 3722-3729
26. Struyf S., Schutyser E., Gouwy M., et al. PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia. Am J Pathol 163 (2003) 2065-2075
27. Matsui I., Tanimura M., Kobayashi N., Sawada T., Nagahara N., and Akatsuka J. Neurofibromatosis type 1 and childhood cancer. Cancer 72 (1993) 2746-2754
28. Shearer P., Parham D., Kovnar E., et al. Neurofibromatosis type 1 and malignancy: review of 32 pediatric cases treated at a single institution. Med Pediatr Oncol 22 (1994) 78-83
29. Stiller C.A., Chessells J.M., and Fitchett M. Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study. Br J Cancer 70 (1994) 969-972
30. Mrozek K., Heerema N.A., and Bloomfield C.D. Cytogenetics in acute leukemia. Blood Rev 18 (2004) 115-136